Hwa Tjeen Anna Lewi Santoso, Viskasari Pintoko Kalanjati

= http://dx.doi.org/10.20473/mbiom.v27i1.2014.9-13
Abstract views = 645 times | downloads = 4749 times


Alzheimer’s disease is becoming an increasing problem in our aging society. This review discusses the disease in a preclinical phase, by using biological markers. In addition, treatment options, with emphasis on new disease-modifying compounds.


Alzheimer’s disease; early diagnosis; biological markers; treatment; penyakit Alzheimer; diagnosa awal; penanda biologis; pengobatan

Full Text:



Allan, C.L. Behrman, S. Ebmeier K.P., 2013. Early Diagnosis beneficial in Alzheimer’s Disease. Symposium. The Practitioner Jan., 2013-257 (1757), hal.15-18.

Carlesimo, G.A. Perri, R. Caltagirone, C., 2011. Category Cued Recall Following Controlled Encoding as a Neuropsychological Toel in the Diagnosis of Alzheimer’s Disease: A Review of the Evidence. Neuropsychol Rev., 21, hal. 54-65.

Darawi, M.N. et al., 2013. Allele-specific polymerase chain reaction for the detection of Alzheimer’s disease related single nucleotide polymorphisms. BMC Medical Genetics, 14, hal.17.

De Rino, F. et al., 2012. CSF metabolite in the differential diagnosis of alzheimer’s disease from frontal variant of frontotemporal dementia. Neurol Sci., 33, hal.973-977.

Engelborghs, S. & Bastard, N.L., 2012. The Impact of Cerebrospinal Fluid Biomarkers on The diagnosis of Alzheimer’s Disease. MolDiagnTher., 16(3), hal.135-141.

Galimberti, D. & Scarpiniet, E., 2012. Progress in Alzheimer’s disease. J neurol., 259, hal.201-211.

Genius, J. et al., 2012. Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer’s disease and other neurodegenerative dementias. ClinNeurosci., 262(Suppl 2), hal. 571-577.

Grela, A. Turek, A. Piekoszewski, W., 2012. Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS) in Alzheimer’s disease. Clin Chem Lab Med., 50(8), hal.1297-1304.

Henkel, A.W. et al., 2012. Multidimensional plasma protein separation technique for identification of potential Alzheimer’s disease plasma biomarkers: a pilot study. J Neural Transm.,119, hal.779-788.

Miller, M.C. et al., 2011. New diagnostic criteria for Alzheimer’s disease. Harvard Mental Health Letter, 28( 2). Diunduh: 31 Desember 2013 dari www.health.harvard.edu subscribe HEALTHbeat.

Wu, L. et al., 2012. Early Onset Familial Alzheimer’s Disease (EOFAD). Can J NeurolSci., 39, hal.436-445.


  • There are currently no refbacks.

Copyright (c) 2019 Majalah Biomorfologi

Majalah Biomorfologi (p-ISSN:0215-8833e-ISSN:2716-0920) is licensed under  Creative Commons Attribution 4.0 International License. 


View Majalah Biomorfologi Statistics


 Indexed By





Universitas Airlangga, Kampus C Mulyorejo, Surabaya 60115, East Java, Indonesia